TITLE

PhRMA Worries About Defecit Reduction Efforts

PUB. DATE
August 2011
SOURCE
Pharmaceutical Representative;Aug2011, Vol. 41 Issue 8, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the opposition of the Pharmaceutical Research and Manufacturers of America (PhRMA) on a proposal to increase drug rebates in the U.S.
ACCESSION #
63988775

 

Related Articles

  • Pharma report shows strength of drug-development in Indiana.  // Indianapolis Business Journal;3/24/2014 Supplement, p13 

    The article discusses the report released by the Pharmaceutical Research and Manufacturers of America (PhRMA), a trade group representing the pharmaceutical research and biopharmaceutical companies in the U.S., on drug developments and clinical trials conducted in Indiana from 1999-2013.

  • PHRMA CELEBRATED. Arnold, Matthew // Medical Marketing & Media;May2010, Vol. 45 Issue 5, p10 

    The article mentions the fifth anniversary of the launch of Pharmaceutical Research and Manufacturers of America's (PhRMA's) Partnership for Prescription Assistance program.

  • Fight Forming on IP Protection.  // BioWorld Today;3/20/2013, Vol. 24 Issue 53, p3 

    The article reports that the Pharmaceutical Research and Manufacturers of America has called for prioritizing intellectual property protection, noting its importance to the development of innovative treatments.

  • PhRMA defends vulnerable Dems. Blake, Aaron; Wilson, Reid // Hill;6/4/2009, Vol. 16 Issue 64, p11 

    The article reports that the Pharmaceutical Research and Manufacturers of America (PhRMA), who managing advertisement promotions for political parties in the U.S. will enjoy early congressional recess, thankful four Democratic freshmen for their early work in Congress.

  • A foot in the door. Paul, Reld // Pharmaceutical Representative;Sep2008, Vol. 38 Issue 9, p3 

    The author reflects on the revised PhRMA code for the pharmaceutical industry in the U.S. He states that the code is one of the most visible steps that the pharmaceutical industry has taken in some time to improve reputation. He adds that critics are quick to point out that the voluntary rules...

  • The Changing Industry-Practitioner Relationship. Sussman, Norman // Primary Psychiatry;Dec2008, Vol. 15 Issue 12, p22 

    Generations of physicians have been accustomed to receiving pens, pads, mugs, and assorted models of the spine, the brain, and other organs, all courtesy of pharmaceutical and medical device manufacturers. Most, if not all, of these gifts will cease as of January 2009, when a new guideline for...

  • Meetings: A Bright Future? Donahue, Marylyn // Pharmaceutical Executive;Sep2009, Vol. 29 Issue 9, p85 

    The article discusses various reports published within the special section of the issue including one on the impact of the revised Pharmaceutical Research and Manufacturers of America (PhRMA) code on healthcare conventions, one on the transformation of exhibit booths as marketing channels, and...

  • Doctor Speak.  // Pharmaceutical Executive;Sep2009, Vol. 29 Issue 9, p90 

    The article presents the responses of healthcare professionals (HCP) about the implementation of the new changes to the Pharmaceutical Research and Manufacturers of America's code in the U.S.

  • Pharmaceutical Industry Leaders Soak Up San Diego's Story. Keshavan, Meghana // San Diego Business Journal;4/22/2013, Vol. 34 Issue 16, p9 

    The article discusses the 2013 annual meeting of the industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA) held in San Diego, California.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics